The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Book Review
PreviousPrevious
Volume 345:1431 November 8, 2001 Number 19
NextNext

The Recombinant DNA Controversy: A Memoir — Science, Politics, and the Public Interest; 1974–1981

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
By Donald S. Fredrickson. 388 pp., illustrated. Washington, D.C., ASM Press, 2001. $39.95. ISBN 1-55581-222-8.

Recombinant DNA technology began in the early 1970s, and it completely changed the world of biology and medicine. In essence, this technology allowed one to combine segments of genetic material from essentially any organism, using simple enzymatic reactions in test tubes, and to propagate the resulting recombinant DNA in living organisms such as Escherichia coli and mammalian cells. Recombinant DNA technology is used in virtually every area of biology, and it is hard to imagine the explosion of biologic information that has occurred over the past 30 years without it. Among the numerous practical benefits of recombinant DNA technology are . . . [Full Text of this Article]




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.